These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1071 related articles for article (PubMed ID: 29627570)

  • 1. Circular RNA hsa_circ_0000673 promotes hepatocellular carcinoma malignance by decreasing miR-767-3p targeting SET.
    Jiang W; Wen D; Gong L; Wang Y; Liu Z; Yin F
    Biochem Biophys Res Commun; 2018 Jun; 500(2):211-216. PubMed ID: 29627570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. circRNA hsa_circ_104566 Sponged miR-338-3p to Promote Hepatocellular Carcinoma Progression.
    Liu G; Guo W; Rao M; Qin J; Hu F; Li K
    Cell Transplant; 2020; 29():963689720963948. PubMed ID: 33028110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular RNA hsa_circ_103809 suppresses hepatocellular carcinoma proliferation and invasion by sponging miR-620.
    Li X; Shen M
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(2):555-566. PubMed ID: 30720163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis.
    Jin J; Liu H; Jin M; Li W; Xu H; Wei F
    Aging (Albany NY); 2020 Jun; 12(12):11623-11635. PubMed ID: 32554866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hsa_circ_0026134 expression promoted TRIM25- and IGF2BP3-mediated hepatocellular carcinoma cell proliferation and invasion via sponging miR-127-5p.
    Zhang W; Zhu L; Yang G; Zhou B; Wang J; Qu X; Yan Z; Qian S; Liu R
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32648571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging roles of hsa_circ_0005075 targeting miR-431 in the progress of HCC.
    Li MF; Li YH; He YH; Wang Q; Zhang Y; Li XF; Meng XM; Huang C; Li J
    Biomed Pharmacother; 2018 Mar; 99():848-858. PubMed ID: 29710484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of circ_0021093 circular RNA forecasts an unfavorable prognosis and facilitates cell progression by targeting the miR-766-3p/MTA3 pathway in hepatocellular carcinoma.
    Liu L; Qi X; Gui Y; Huo H; Yang X; Yang L
    Gene; 2019 Sep; 714():143992. PubMed ID: 31330234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CircRNA hsa_circRNA_104348 promotes hepatocellular carcinoma progression through modulating miR-187-3p/RTKN2 axis and activating Wnt/β-catenin pathway.
    Huang G; Liang M; Liu H; Huang J; Li P; Wang C; Zhang Y; Lin Y; Jiang X
    Cell Death Dis; 2020 Dec; 11(12):1065. PubMed ID: 33311442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular RNA hsa_circ_0016788 regulates hepatocellular carcinoma tumorigenesis through miR-486/CDK4 pathway.
    Guan Z; Tan J; Gao W; Li X; Yang Y; Li X; Li Y; Wang Q
    J Cell Physiol; 2018 Jan; 234(1):500-508. PubMed ID: 29923236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. hsa_circ_0000092 promotes hepatocellular carcinoma progression through up-regulating HN1 expression by binding to microRNA-338-3p.
    Pu J; Wang J; Li W; Lu Y; Wu X; Long X; Luo C; Wei H
    J Cell Mol Med; 2024 Mar; 28(6):e15010. PubMed ID: 32077624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of circ_HIPK3 inhibits tumorigenesis of hepatocellular carcinoma via the miR-582-3p/DLX2 axis.
    Zhang H; Dai Q; Zheng L; Yuan X; Pan S; Deng J
    Biochem Biophys Res Commun; 2020 Dec; 533(3):501-509. PubMed ID: 32977948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma.
    Yu J; Xu QG; Wang ZG; Yang Y; Zhang L; Ma JZ; Sun SH; Yang F; Zhou WP
    J Hepatol; 2018 Jun; 68(6):1214-1227. PubMed ID: 29378234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Has_circ_0008583 modulates hepatocellular carcinoma progression through the miR-1301-3p/METTL3 pathway.
    Wang F; Xie Z; Zhang N; Ding H; Xiong K; Guo L; Huang H; Wen Z
    Bioengineered; 2022 Jan; 13(1):1185-1197. PubMed ID: 35258395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hsa_circ_0016788 regulates hepatocellular carcinoma progression via miR-506-3p/poly-adenosine diphosphate-ribose polymerase.
    Chen M; Hu G; Zhou X; Peng Z; Wen W
    J Gastroenterol Hepatol; 2021 Dec; 36(12):3457-3468. PubMed ID: 34340259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of circular RNA circ_001569 indicates poor prognosis in hepatocellular carcinoma and promotes cell growth and metastasis by sponging miR-411-5p and miR-432-5p.
    Liu H; Xue L; Song C; Liu F; Jiang T; Yang X
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2659-2665. PubMed ID: 30086881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsa_circ_101280 promotes hepatocellular carcinoma by regulating miR-375/JAK2.
    Cao S; Wang G; Wang J; Li C; Zhang L
    Immunol Cell Biol; 2019 Feb; 97(2):218-228. PubMed ID: 30302825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CircRNA hsa_circ_0110102 inhibited macrophage activation and hepatocellular carcinoma progression via miR-580-5p/PPARα/CCL2 pathway.
    Wang X; Sheng W; Xu T; Xu J; Gao R; Zhang Z
    Aging (Albany NY); 2021 Apr; 13(8):11969-11987. PubMed ID: 33891564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1.
    Song LN; Qiao GL; Yu J; Yang CM; Chen Y; Deng ZF; Song LH; Ma LJ; Yan HL
    J Exp Clin Cancer Res; 2020 Jun; 39(1):114. PubMed ID: 32552766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA hsa_circ_0051040 Promotes Hepatocellular Carcinoma Progression by Sponging miR-569 and Regulating ITGAV Expression.
    Ju L; Yao M; Lu R; Cao Y; Wang H; Yuan L; Xiao F; Shao J; Cai W; Chen L; Bian Z
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma.
    Liu L; Yang X; Li NF; Lin L; Luo H
    Cell Cycle; 2019 Nov; 18(21):2939-2953. PubMed ID: 31522588
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 54.